Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.
Kent DM, Hayward RA. Kent DM, et al. JAMA. 2007 Sep 12;298(10):1209-12. doi: 10.1001/jama.298.10.1209. JAMA. 2007. PMID: 17848656 No abstract available.
The potential use of ECG-based prognostic instruments in clinical trials and cost-effectiveness analyses of new therapies in acute cardiac ischemia.
Kent DM, Langa KM, Selker HP. Kent DM, et al. J Electrocardiol. 2000;33 Suppl:263-8. doi: 10.1054/jelc.2000.20301. J Electrocardiol. 2000. PMID: 11265732
Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing.
Kent DM, Lau J, Selker HP. Kent DM, et al. Eff Clin Pract. 2001 Sep-Oct;4(5):214-20. Eff Clin Pract. 2001. PMID: 11685979
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
Kent DM, Hayward RA, Griffith JL, Vijan S, Beshansky JR, Califf RM, Selker HP. Kent DM, et al. Am J Med. 2002 Aug 1;113(2):104-11. doi: 10.1016/s0002-9343(02)01160-9. Am J Med. 2002. PMID: 12133748
Is primary angioplasty for some as good as primary angioplasty for all?
Kent DM, Schmid CH, Lau J, Selker HP. Kent DM, et al. J Gen Intern Med. 2002 Dec;17(12):887-94. doi: 10.1046/j.1525-1497.2002.11232.x. J Gen Intern Med. 2002. PMID: 12472924 Free PMC article.
Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
Kent DM, Ruthazer R, Selker HP. Kent DM, et al. Stroke. 2003 Feb;34(2):464-7. doi: 10.1161/01.str.0000051506.43212.8b. Stroke. 2003. PMID: 12574561
Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
Kent DM, Mwamburi M, Cash RA, Rabin TL, Bennish ML. Kent DM, et al. Am J Bioeth. 2003 Spring;3(2):W11. doi: 10.1162/152651603322874898. Am J Bioeth. 2003. PMID: 14635629
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
Kent DM, Hinchey J, Price LL, Levine SR, Selker HP. Kent DM, et al. Stroke. 2004 May;35(5):1141-6. doi: 10.1161/01.STR.0000125712.02090.6e. Epub 2004 Apr 15. Stroke. 2004. PMID: 15087567
New and dis-improved: on the evaluation and use of less effective, less expensive medical interventions.
Kent DM, Fendrick AM, Langa KM. Kent DM, et al. Med Decis Making. 2004 May-Jun;24(3):281-6. doi: 10.1177/0272989X04265478. Med Decis Making. 2004. PMID: 15155017
Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials.
Kent DM, Mwamburi DM, Bennish ML, Kupelnick B, Ioannidis JP. Kent DM, et al. JAMA. 2004 Jul 14;292(2):237-42. doi: 10.1001/jama.292.2.237. JAMA. 2004. PMID: 15249573 Review.
209 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback